CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...